Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Thiomorpholine | HCID 67164 | — |
| Reactant | Tris(1,1-dimethylethyl)phosphine | HCID 83681 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Reactant | HCID 58531012 | HCID 58531012 | — |
| Catalyst | Tris(dibenzylideneacetone) dipalladium | HCID 9832798 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 86659723 | HCID 86659723 | 57% |
Reaction Steps
To a solution of 2-(4-bromophenyl)-5-chloro-7-morpholin-4-yl-pyrazolo[1,5-a]-pyrimidine (100 mg, 0.25 mM) in toluene (7.0 mL), there were, in order, added sodium tert-butoxide (49 mg, 0.51 mM), tris(dibenzylidene-acetone) dipalladium (12 mg, 0.013 mM), tri-tert-butyl-phosphine (25 μL, 0.10 mM) and thio-morpholine (38 μL, 0.38 mM) and the mixture was stirred at 90° C. for 4 hours. After cooling the mixture to room temperature, water was added thereto and the mixture was extracted with ethyl acetate. The organic phase thus obtained was washed with a saturated aqueous common salt solution, dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The resulting residue was washed with methanol to thus give the title compound (60 mg, yield: 57%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08314098B2 |
|---|
| Source dataset | uspto-grants-2012_11 |
|---|
| ORD ID | ord-7e03dfb5a88a4759b91e698471f421ec |
|---|
| Source note | uspto-grants-2012_11 |
|---|